Pilot study of on-demand therapy with pantoprazole 20mg for long-term treatment in patients with mild gastro-oesophageal reflux disease

Clinical Drug Investigation

Volumn 25, Issue 10, 2005, Pages 633-642

  Scholten, Theo ^a   Pustlauk, Uwe ^b   Sander, Peter ^a   Bohuschke, Martina ^a   Gatz, Gudrun ^a  

^a University Hospital of Witten Herdecke   (Germany)

^b ALTANA Pharma AG ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; MAGALDRATE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BACKACHE; BLOATING; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG WITHDRAWAL; ECZEMA; EPIGASTRIC PAIN; ERUCTATION; FEMALE; FEVER; FLU LIKE SYNDROME; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; INJURY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHARYNGITIS; PRIORITY JOURNAL; RELAPSE; RHINITIS; SALVAGE THERAPY; SYMPTOM; TABLET; TOOTH PAIN; TREATMENT FAILURE;

EID: 24944513399     PISSN: 11732563     EISSN: 11732563     Source Type: Journal    
DOI: 10.2165/00044011-200525100-00002     Document Type: Article

References (36)

1. Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992; 51 Suppl. 1: 24-9
2. Wienbeck M, Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 1989; 156: 7-13
3. Tytgat GN, Nio CY, Schotborgh RH. Reflux esophagitis. Scand J Gastroenterol Suppl 1990; 175: 1-12
4. Schepp W. Proton pump inhibitory therapy: then and now. Yale J Biol Med 1996 Mar-Apr; 69 (2): 175-186
5. Berardi RR. A critical evaluation of proton pump inhibitors in the treatment of gastroesophageal reflux disease. Am J Manag Care 2000 May; 6 (9 Suppl.): S491-505
6. Bardhan KD. The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1995; 9 Suppl. 1: 15-25
7. Chiba N. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview. Can J Gastroenterol 1997 Sep; 11 Suppl. B: 66B-73B
8. Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 1998 Feb; 10 (2): 119-24
9. Vigneri S, Termini R, Leandro G, et al. Comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995 Oct 26; 333 (17): 1106-10
10. Klinkenberg-Knol EC, Festen HP, Jansen JB, et al. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994 Aug 1; 121 (3):161-7
11. Bardhan KD. Pantoprazole: a new proton pump inhibitor in the management of upper gastrointestinal disease. Drugs Today 1999; 35 (10): 773-808
12. Lee JM, O'Morain CA. Trends in the management of gastrooesophageal reflux disease. Postgrad Med J 1998 Mar; 74 (869): 145-50
13. Schindlbeck NE, Klauser AG, Berghammer G, et al. Three year follow up of patients with gastrooesophageal reflux disease. Gut 1992 Aug; 33 (8): 1016-9
14. Talley NJ, Lauritsen K, Tunturi-Hihnala H, et al. Esomeprazole 20mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther 2001 Mar; 15 (3): 347-54
15. Talley NJ, Venables TL, Green JR, et al. Esomeprazole 40mg and 20mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. Eur J Gastroenterol Hepatol 2002 Aug; 14 (8): 857-63
16. Lind T, Havelund T, Lundell L, et al. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis: a placebo-controlled randomized trial. Aliment Pharmacol Ther 1999 Jul; 13 (7): 907-14
17. Wahlqvist P, Junghard O, Higgins A, et al. Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies. Pharmacoeconomics 2002; 20 (4): 267-77
18. Scholten T, Dekkers CPM, Schütze K, et al. On-demand therapy with pantoprazole 20mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial. Digestion 2005 Aug 19; 72 (2): 76-85
19. Kaspari S, Kupcinskas L, Heinze H, et al. On-demand therapy with pantoprazole 20mg as effective long-term management of patients suffering from mild GERD. Eur J Gastroenterol Hepatol 2005; 17: 935-41
20. Janssen W, Meier E, Gatz G, et al. Pantoprazole 20mg on-demand and continuous are comparably effective for long-term management of patients with mild GERD. Current Therapeutic Res 2005; 66 (4): 345-63
21. Savary M, Miller G. Das Oesophagus-Lehrbuch und endos-kopischer Atlas. Soluthurn: Gassmann, 1977
22. Siewert JR, Ottenjann R, Heilmann K, et al. Therapy and prevention of reflux esophagitis. Results of a multicenter study with cimetidine. I. Epidemiology and results of acute therapy. Z Gastroenterol 1986; 24: 381-95
23. Armstrong D, Pare P, Pericak D. Canadian Pantoprazole GERD Study Group. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. Am J Gastroenterol 2001 Oct; 96 (10): 2849-57
24. Lehmann FS, Beglinger C. Role of pantoprazole in the treatment of gastro-oesophageal reflux disease. Expert Opin Pharmacother 2005 Jan; 6 (1): 93-104
25. Scholten T, Gatz G, Hole U. Once-daily pantoprazole 40mg and esomeprazole 40mg have equivalent overall efficacy in relieving GERD-related symptoms. Aliment Pharmacol Ther 2003 Sep 15; 18 (6): 587-94
26. Richter JE, Fraga P, Mack M, et al. Prevention of erosive oesophagitis relapse with pantoprazole. Aliment Pharmacol Ther 2004 Sep 1; 20 (5): 567-75
27. Caro JJ, Salas M, Ward A. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. Clin Ther 2001 Jul; 23 (7): 998-1017
28. Kaspari S, Biedermann A, Mey J. Comparison of pantoprazole 20mg to ranitidine 150mg b.i.d. in the treatment of mild gastroesophageal reflux disease. Digestion 2001; 63 (3): 163-70
29. van Zyl JH, de K Grundling H, van Rensburg CJ, et al. Efficacy and tolerability of 20mg pantoprazole versus 300mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study. Eur J Gastroenterol Hepatol 2000 Feb; 12 (2): 197-202
30. Ramírez-Barba EJ, Dibildox M, Bernal F, et al. Low-dose pantoprazole (20mg) is effective for treatment of mild reflux oesophagitis. Clin Drug Invest 1999; 18 (6): 445-51
31. Bytzer P, Blum A, De Herdt D, et al. Six-month trial of on-demand rabeprazole 10mg maintains symptom relief in patients with non-erosive reflux disease. Aliment Pharmacol Ther 2004 Jul 15; 20 (2): 181-8
32. Venables TL, Newland RD, Patel AC, et al. Maintenance treatment for gastro-oesophageal reflux disease: a placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice. Scand J Gastroenterol 1997 Jul; 32 (7): 627-32
33. Escourrou J, Deprez P, Saggioro A, et al. Maintenance therapy with pantoprazole 20mg prevents relapse of reflux oesophagitis. Aliment Pharmacol Ther 1999 Nov; 13 (11): 1481-91
34. Bate CM, Booth SN, Crowe JP, et al. Omeprazole 10mg or 20mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group. Gut 1995 Apr; 36 (4): 492-8
35. Lauritsen K, Jaup B, Carling L, et al. Comparable efficacy of pantoprazole and omeprazole to prevent relapse in patients with GERD. Gut 2000; 47 (Suppl III): 39 [A60]
36. Johnsson F, Moum B, Vilien M, et al. On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole. Scand J Gastroenterol 2002 Jun; 37 (6): 642-7